Compounding has provided a temporary solution for patients facing high out-of-pocket costs for essential medications, but uncertainty looms as shortages may soon end. Insurance coverage remains a significant hurdle, with potential changes on the horizon that could affect access to obesity drugs. As research evolves, new benefits and side effects of these medications may emerge, leaving patients navigating a complex landscape of options and risks.
